CAS No.: 1562338-42-4
5-(1H-Pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol Catalog No. CSN17932
Synonyms: LMI070;NVS-SM1
LMI070 is a highly potent, selective and orally active small molecule SMN2 splicing modulator.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT02268552 Spinal Muscular Atrophy Phase 1 Phase 2 Recruiting July 23, 2020 Belgium ... more >> Novartis Investigative Site Recruiting Gent, Belgium, 9000 Novartis Investigative Site Recruiting Leuven, Belgium, 3000 Bulgaria Novartis Investigative Site Recruiting Sofia, Bulgaria, 1606 Czechia Novartis Investigative Site Recruiting Prague 5, CZE, Czechia, 15006 Denmark Novartis Investigative Site Recruiting Copenhagen, Denmark, 2100 O Germany Novartis Investigative Site Completed Essen, Germany, 45147 Novartis Investigative Site Withdrawn Freiburg, Germany, 79106 Italy Novartis Investigative Site Recruiting Roma, ITA, Italy, 00165 Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Poland Novartis Investigative Site Recruiting Warsaw, Poland, 04-730 Novartis Investigative Site Recruiting Wroclaw, Poland, 50-420 Russian Federation Novartis Investigative Site Recruiting Ekaterinburg, Russian Federation Novartis Investigative Site Recruiting Saint Petersburg, Russian Federation, 197341 Novartis Investigative Site Recruiting Ufa, Russian Federation, 450000 Collapse <<
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1562338-42-4 | 储存条件 |
|
|||||||
| 分子式 | C22H27N5O2 | 运输 | 蓝冰 | |||||||
| 分子量 | 393.48 | 别名 | LMI070;NVS-SM1 | |||||||
| 溶解度 |
|
动物实验配方 |
